- Home
- AORT
AORT
Artivion Inc.
as 11-15-2024 4:00pm EST
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others.
| Founded: | 1984 | Country: | United States |
| Employees: | N/A | City: | KENNESAW |
| Market Cap: | 1.1B | IPO Year: | 1993 |
| Target Price: | $31.00 | AVG Volume (30 days): | 224.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.03 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.42 - $30.00 | Next Earning Date: | 11-07-2024 |
| Revenue: | $384,899,000 | Revenue Growth: | 13.29% |
| Revenue Growth (this year): | 12.93% | Revenue Growth (next year): | 9.89% |
Stock Insider Trading Activity of Artivion Inc. (AORT)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Horton Amy | AORT | VP, Chief Accounting Officer | Oct 1 '24 | Sell | $26.18 | 12,430 | $325,414.91 | 139,989 | |
| Holloway Jean F | AORT | SVP, General Counsel | Aug 26 '24 | Sell | $26.55 | 3,167 | $84,095.88 | 161,932 |
Latest Artivion Inc. News
AORT Breaking Stock News: Dive into AORT Ticker-Specific Updates for Smart Investing
Argus Research
4 days ago
AORT: What does Argus have to say about AORT?
Simply Wall St.
8 days ago
Artivion Third Quarter 2024 Earnings: Beats Expectations
PR Newswire
10 days ago
Artivion Reports Third Quarter 2024 Financial Results
Argus Research
11 days ago
AORT: Raising target price to $22.00
PR Newswire
12 days ago
Artivion to Participate in Upcoming Investor Conferences
PR Newswire
24 days ago
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results
PR Newswire
a month ago
Artivion Announces Presentation of Late-Breaking Clinical Data at the 38th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting
Argus Research
a month ago
AORT: Lowering target price to $27.00
Compare AORT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AORT Artivion Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.